Scripps Health has patented a method to produce chondrocytes from stem cells and regenerate cartilaginous tissue. The process involves culturing pluripotent cells, generating specific protein-expressing cells, and transplanting them into bone or cartilage defects for tissue regeneration. GlobalData’s report on Scripps Health gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
According to GlobalData’s company profile on Scripps Health, was a key innovation area identified from patents. Scripps Health's grant share as of February 2024 was 55%. Grant share is based on the ratio of number of grants to total number of patents.
Regenerating cartilaginous tissue from pluripotent stem cells
A recently granted patent (Publication Number: US11859210B2) discloses a method for regenerating cartilaginous tissue using pluripotent cells. The method involves culturing these cells on tissue culture-grade plastic, passaging them multiple times to express specific proteins, and then culturing them in a three-dimensional environment to generate chondrogenic precursor cells. These precursor cells are then transplanted into bone or cartilage defects to produce regenerated cartilaginous tissue within the defect.
Furthermore, the method includes additional steps such as mechanically dissecting pluripotent cell aggregates, using chondrogenic growth factors in the three-dimensional culture, and integrating the chondrogenic precursor cells into biomaterials. The regenerated cartilaginous tissue resulting from this method is characterized by its seamless integration with the surrounding tissue, restoration of the bone or cartilage surface, and composition including collagen type II and lubricin. The regenerated tissue does not exhibit teratoma formation, neoplastic cells, or non-chondrogenic features, ensuring a successful and safe regeneration process.
To know more about GlobalData’s detailed insights on Scripps Health, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
